Journals / European Journal of Therapeutics / 2022 / Cilt: 28 - Sayı: 1

Hashimoto’s Thyroiditis is Not a Negative Contributor to Papillary Thyroid Cancer

Pages
30–36
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to these findings, Hashimoto’s thyroiditis may be a risk factor for papillary thyroid cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Hashimoto’s thyroiditis is the most common autoimmune thyroid disease.
📊
Key Findings & Data:Methods: In this study, 534 patients were screened retrospectively.
💡
Conclusion & Impact:According to these findings, Hashimoto’s thyroiditis may be a risk factor for papillary thyroid cancer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Hashimoto’s thyroiditis is the most common autoimmune thyroid disease. Papillary thyroid cancer is the most common thyroid cancer. Whether Hashimoto’s thyroiditis is a predisposing factor for papillary thyroid cancer remains unclear. In this study, the frequency of papillary thyroid cancer was investigated in patients with Hashimoto’s thyroiditis who underwent total thyroidectomy. Methods: In this study, 534 patients were screened retrospectively. Preoperative thyroid function tests, anti-thyroid antibodies, ultrasonography findings, fine-needle aspiration biopsies, and thyroidectomy pathology results were examined. According to the pathology, 139 patients had Hashimoto’s thyroiditis. Patients with Hashimoto’s thyroiditis (group 1) and non-Hashimoto’s thyroiditis (group 2) were compared. Results: Papillary thyroid cancer was found in 70 patients (50.4%) in group 1 and 156 patients (39.5%) in group 2 (P=.026). The odds ratio was 1.59 (95% CI; 1.07-2.34). There was no difference for sex, age, tumor size, microcarcinoma–macrocarcinoma distribution, subtype, number of tumor focus, lymph node metastasis, vessel invasion, and extrathyroidal spread. Conclusion: We found more papillary thyroid cancer and less capsular invasion in patients with Hashimoto’s thyroiditis, but we did not find any differences between groups in terms of age, gender, tumor size, vascular invasion, and metastasis. According to these findings, Hashimoto’s thyroiditis may be a risk factor for papillary thyroid cancer.

🔖

Cite This Article

ÇETİN, Z., GÜLER, S., BAŞER, Ö. (2022). Hashimoto’s Thyroiditis is Not a Negative Contributor to Papillary Thyroid Cancer. European Journal of Therapeutics, Cilt: 28 - Sayı: 1, 30–36. https://ajindex.com/articles/512121

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Jankovic B, Le KT, Hershman JM. Clinical Review: Hashimoto’s thyroiditis and papillary thyroid carcinoma: is there a correlation? J Clin Endocrinol Metab. 2013
  2. 98(2):474-482. [CrossRef] 2. Ozmen S, Yılmaz HT, Çalik I, et al. Histopathological results of suspicious nodules in the patients with Hashimoto thyroiditis. BSJ Health Sci. 2020
  3. 3(1):8-11. 3. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006
  4. 295(18):2164-2167. [CrossRef] 4. Baser H, Ozdemir D, Cuhaci N, et al. Hashimoto’s thyroiditis does not affect ultrasonographical, cytological and histopathological feautres in patients with papillary thyroid carcinoma. Endocr Pathol. 2015
  5. 26(4):356-364. [CrossRef] 5. Girardi FM, Barra MB, Zettler CG. Papillary thyroid carcinoma: does the association with Hashimoto’s thyroiditis affect the clinicopathological characteristics of the disease? Braz J Otorhinolaryngol. 2015
  6. 81(3):283-287. [CrossRef] 6. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology. Definitions, Criteria and Explanatory Notes. New York: Springer
  7. Uhliarova B, Hajtman A. Hashimoto’s thyroiditis - an independent risk factor for papillary carcinoma. Braz J Otorhinolaryngol. 2018
  8. 84(6):729-735. [CrossRef] 8. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014
  9. 13(4-5):391-397. [CrossRef] 9. Mazokopakis EE, Tzortzinis AA, Dalieraki-Ott EI, et al. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study. Hormones (Athens). 2010
  10. 9(4):312-317. [CrossRef] 10. Mazokopakis EE, Kotsiris DA. Hashimoto's autoimmune thyroiditis and vitamin D deciency. Current aspects. Hell J Nucl Med. 2014
  11. 17(1):37-40. [CrossRef] 11. Anderson L, Middleton WD, Teefey SA, et al. Hashimoto thyroiditis: Part 2, sonographic analysis of benign and malignant nodules in patients with diffuse Hashimoto thyroiditis. AJR Am J Roentgenol. 2010
  12. 195(1):216-222. [CrossRef] 12. Azizi G, Keller JM, Lewis M, et al. Association of Hashimoto’s thyroiditis with thyroid cancer. Endocr Relat Cancer. 2014
  13. 21(6):845-852. [CrossRef] 13. Spencer CA. Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab. 2011
  14. 96(12):3615-3627. [CrossRef] 14. Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in ultr